Sensus Healthcare, Inc. (SRTS) — Financial statements
Income statement, balance sheet, and cash flow for Sensus Healthcare, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 27↓34.3% | 42↑71.3% | 24↓45.2% | 45↑64.7% | 27 | |
| Cost of Revenue | 16↓10.1% | 17↑68.0% | 10↓30.6% | 15↑48.2% | 10 | |
| Gross Profit | 12↓51.4% | 24↑73.8% | 14↓52.5% | 30↑74.4% | 17 | |
| Operating Expenses | ||||||
| R&D Expenses | 8↑84.5% | 4↑14.6% | 4↑6.3% | 3↑0.7% | 3 | |
| General & Administrative Expenses | 8↑10.2% | 7↑38.6% | 5↑3.0% | 5↑9.0% | 5 | |
| Selling & Marketing Expenses | 7↑31.0% | 5↓11.2% | 6↓11.4% | 6↑30.8% | 5 | |
| SG&A Expenses | 14↑18.7% | 12↑12.6% | 11↓5.1% | 11↑20.2% | 9 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 22↑35.7% | 16↑13.1% | 14↓2.4% | 15↑15.0% | 13 | |
| Total Costs & Expenses | 38↑12.1% | 34↑36.0% | 25↓16.5% | 30↑29.6% | 23 | |
| Operating Results | ||||||
| Operating Income | -10↓227.4% | 8↑2217.8% | -0.38↓102.6% | 15↑260.0% | 4 | |
| Depreciation & Amortization | 0.39↓10.6% | 0.43↓6.3% | 0.46↓9.4% | 0.51↓17.0% | 0.61 | |
| EBITDA | -10↓216.4% | 9↑10687.3% | 0.08↓99.5% | 15↑224.0% | 5 | |
| EBIT | -10↓227.4% | 8↑2217.8% | -0.38↓102.6% | 15↑259.9% | 4 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.68↓26.7% | 0.93↓6.0% | 0.99↑161.1% | 0.38↑37900.0% | 0.00 | |
| Interest Income | 0.68↓26.7% | 0.93↓6.0% | 0.99↑159.7% | 0.38↑19000.0% | 0.00 | |
| Interest Expense | 0.00 | 0.00 | 0.00↓100.0% | 0.00↑100.0% | 0.00 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00↑100.0% | -0.00 | |
| Other Income / Expenses | 0.68↓26.7% | 0.93↓9.9% | 1↓92.1% | 13↑1316000.0% | -0.00 | |
| Income Before Tax | -10↓206.7% | 9↑1283.7% | 0.65↓97.7% | 28↑579.5% | 4 | |
| Income Tax Expense | -2↓180.2% | 2↑1322.2% | 0.17↓95.5% | 4 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -8↓216.1% | 7↑1270.5% | 0.49↓98.0% | 24↑488.6% | 4 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -8↓216.1% | 7↑1270.5% | 0.49↓98.0% | 24↑488.6% | 4 | |
| Bottom-Line Net Income | -8↓216.1% | 7↑1270.5% | 0.49↓98.0% | 24↑488.6% | 4 | |
| EPS (Basic) | -0.47↓214.6% | 0.41↑1275.8% | 0.03↓98.0% | 1.47↑488.0% | 0.25 | |
| EPS (Diluted) | -0.47↓214.6% | 0.41↑1275.8% | 0.03↓98.0% | 1.46↑484.0% | 0.25 | |
| Weighted Average Shares | 16↑0.1% | 16↑0.3% | 16↓1.3% | 16↑0.0% | 16 | |
| Weighted Average Diluted Shares | 16↓0.2% | 16↑0.6% | 16↓2.1% | 17↑0.7% | 17 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.